ArticleTransplantation direct2021

Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients.

Christopher J Mowry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.